BioAtla, Inc. Uncategorized Contracts & Agreements
14 Contracts & Agreements
- Global Transaction Agreement between BioAtla, Inc. and Himalaya Therapeutics SEZC, dated as of September 23, 2024 (Filed With SEC on September 23, 2024)
- Description of Securities (Filed With SEC on March 26, 2024)
- Open Market Sale AgreementSM, dated as of January 6, 2023, between BioAtla, Inc. and Jefferies LLC (Filed With SEC on January 6, 2023)
- Offer Letter between BioAtla, LLC and Christian Vasquez, dated October 22, 2015 (Filed With SEC on February 28, 2022)
- Offer Letter between BioAtla, LLC and Eric Sievers, dated June 17, 2019 (Filed With SEC on February 28, 2022)
- Offer Letter between BioAtla, LLC and Richard Waldron, dated October 23, 2013 (Filed With SEC on February 28, 2022)
- Description of Securities (Filed With SEC on February 28, 2022)
- Description of Securities (Filed With SEC on March 24, 2021)
- Letter Agreement between BioAtla, LLC and Scott Smith, dated August 3, 2018 (Filed With SEC on December 8, 2020)
- Offer Letter between BioAtla, LLC and Scott Smith, dated August 2, 2018 (Filed With SEC on December 8, 2020)
- Offer Letter between BioAtla, LLC and Carolyn Short, dated November 30, 2015 (Filed With SEC on December 8, 2020)
- Right of First Refusal and Co-Sale Agreement, dated July 13, 2020 (Filed With SEC on December 8, 2020)
- Royalty Sharing Agreement with BioAtla Holdings, LLC, dated January 1, 2020 (Filed With SEC on November 13, 2020)
- Exclusive Rights Agreement with Himalaya SEZC, dated January 1, 2020 (Filed With SEC on November 13, 2020)
